120 related articles for article (PubMed ID: 21807392)
1. Low dose of insulin detemir controls glycaemia, insulinemia and prevents diabetes mellitus progression in the dog with pituitary-dependent hyperadrenocorticism.
Miceli DD; Gallelli MF; Cabrera Blatter MF; Martiarena B; Brañas MM; Ortemberg LR; Gómez NV; Castillo VA
Res Vet Sci; 2012 Aug; 93(1):114-20. PubMed ID: 21807392
[TBL] [Abstract][Full Text] [Related]
2. Na(+), K(+)-ATPase content in skeletal muscle of dogs with pituitary-dependent hyperadrenocorticism.
Schotanus BA; Meij BP; Vos IH; Kooistra HS; Everts ME
Domest Anim Endocrinol; 2006 May; 30(4):320-32. PubMed ID: 16202554
[TBL] [Abstract][Full Text] [Related]
3. Blindness in dogs with pituitary dependent hyperadrenocorticism: relationship with glucose, cortisol and triglyceride concentration and with ophthalmic blood flow.
Cabrera Blatter MF; del Prado A; Gallelli MF; D'Anna E; Ivanic J; Esarte M; Miceli DD; Gómez NV; Castillo VA
Res Vet Sci; 2012 Jun; 92(3):387-92. PubMed ID: 21575979
[TBL] [Abstract][Full Text] [Related]
4. Concurrent hyperadrenocorticism and diabetes mellitus in dogs.
Miceli DD; Pignataro OP; Castillo VA
Res Vet Sci; 2017 Dec; 115():425-431. PubMed ID: 28759861
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
Feldman EC; Nelson RW; Feldman MS; Farver TB
J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
[TBL] [Abstract][Full Text] [Related]
6. Update on drugs used to treat endocrine diseases in small animals.
Behrend EN
Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):1087-105, vii. PubMed ID: 16984828
[TBL] [Abstract][Full Text] [Related]
7. Involvement of glucagon-like peptide 1 in the glucose homeostasis regulation in obese and pituitary-dependent hyperadrenocorticism affected dogs.
Miceli DD; Cabrera Blatter MF; Gallelli MF; Pignataro OP; Castillo VA
Res Vet Sci; 2014 Oct; 97(2):211-7. PubMed ID: 25128418
[TBL] [Abstract][Full Text] [Related]
8. Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism.
Peterson ME; Altszuler N; Nichols CE
Res Vet Sci; 1984 Mar; 36(2):177-82. PubMed ID: 6371957
[TBL] [Abstract][Full Text] [Related]
9. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
Meneghini L; Koenen C; Weng W; Selam JL
Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
[TBL] [Abstract][Full Text] [Related]
10. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism.
Ortega TM; Feldman EC; Nelson RW; Willits N; Cowgill LD
J Am Vet Med Assoc; 1996 Nov; 209(10):1724-9. PubMed ID: 8921029
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte insulin receptors in dogs with spontaneous hyperadrenocorticism.
Wolfsheimer KJ; Peterson ME
Am J Vet Res; 1991 Jun; 52(6):917-21. PubMed ID: 1883096
[TBL] [Abstract][Full Text] [Related]
12. Time-action profiles of insulin detemir in normal and diabetic dogs.
Sako T; Mori A; Lee P; Oda H; Saeki K; Miki Y; Kurishima M; Mimura K; Nozawa S; Mizutani H; Makino Y; Ishioka K; Arai T
Res Vet Sci; 2011 Jun; 90(3):396-403. PubMed ID: 20708207
[TBL] [Abstract][Full Text] [Related]
13. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: a case report.
Galac S; Kars VJ; Voorhout G; Mol JA; Kooistra HS
Vet J; 2008 Jul; 177(1):141-3. PubMed ID: 17572120
[TBL] [Abstract][Full Text] [Related]
14. Retrospective evaluation of the effect of trilostane on insulin requirement and fructosamine concentration in eight diabetic dogs with hyperadrenocorticism.
McLauchlan G; Knottenbelt C; Augusto M; Helm J; McGrotty Y; Ramsey I
J Small Anim Pract; 2010 Dec; 51(12):642-8. PubMed ID: 21121919
[TBL] [Abstract][Full Text] [Related]
15. Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism.
Feldman EC; Bruyette DS; Nelson RW; Farver TB
J Am Vet Med Assoc; 1990 Jul; 197(1):71-8. PubMed ID: 2370223
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism.
Mack RE; Feldman EC
J Am Vet Med Assoc; 1990 Dec; 197(12):1603-6. PubMed ID: 2177458
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
Thuróczy J; Balogh L; Huszenicza G; Jánoki GA; Kulcsár M
Acta Vet Hung; 1998; 46(2):157-73. PubMed ID: 9704520
[TBL] [Abstract][Full Text] [Related]
18. [Our experience in continuous administration of insulin using infusion dispenser at a metabolic intensive care unit (MICU)].
Charvát J; Pálová S; Horácková M; Kratochvíl J; Masopust J
Vnitr Lek; 2007 Oct; 53(10):1047-52. PubMed ID: 18072428
[TBL] [Abstract][Full Text] [Related]
19. A preliminary evaluation of the circulating leptin/adiponectin ratio in dogs with pituitary-dependent hyperadrenocorticism and concurrent diabetes mellitus.
Kim H; Kang JH; Jung DI; Kang BT; Chang D; Yang MP
Domest Anim Endocrinol; 2021 Jan; 74():106506. PubMed ID: 32920447
[TBL] [Abstract][Full Text] [Related]
20. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
